New pill tested to fight aggressive brain cancers

NCT ID NCT06047379

Summary

This study is testing a new oral medication called NEO212 for adults with specific aggressive brain tumors (like glioblastoma) or brain metastases from other cancers. The main goals are to find a safe and effective dose, see how the body processes the drug, and check if it can help control the cancer in the brain. Participants will take the pill daily for five days each month.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor, Scott and White Research Institute

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact

    Contact Email: •••••@•••••

  • Northwest Medical Specialties

    RECRUITING

    Tacoma, Washington, 98405, United States

    Contact

    Contact Phone: •••-•••-••••

  • OPN Healthcare, Inc

    RECRUITING

    Glendale, California, 91203, United States

    Contact Email: •••••@•••••

    Contact

  • Precision NextGen Oncology

    RECRUITING

    Beverly Hills, California, 90212, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Southern California

    RECRUITING

    Los Angeles, California, 90033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact

Conditions

Explore the condition pages connected to this study.